{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:03:18Z","timestamp":1756425798790,"version":"3.44.0"},"reference-count":21,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,9,7]]},"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:p>Both encapsulating peritoneal sclerosis (EPS) and calciphylaxis are rare but severe complications involving patients with end-stage renal disease. In this report, we discuss a unique case of a 73-year-old female patient who had undergone 8 years of peritoneal dialysis for IgA nephropathy and concurrently developed these two synchronous complications within 3 months of each other. Diagnosis and management of both conditions were discussed in detail as well as the possible association between the two. With surgical treatment for EPS and measures to minimise bone mineral disorder abnormalities, both complications have been successfully managed to date.<\/jats:p>","DOI":"10.1136\/bcr-2021-245156","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T12:40:11Z","timestamp":1648039211000},"page":"e245156","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Concurrent development of encapsulating peritoneal sclerosis and calciphylaxis in a patient with peritoneal dialysis for end-stage renal disease"],"prefix":"10.1136","volume":"15","author":[{"given":"Khine Myat","family":"Win","sequence":"first","affiliation":[{"name":"Trauma and Orthopaedics, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9047-2276","authenticated-orcid":false,"given":"Rute","family":"Castelhano","sequence":"additional","affiliation":[{"name":"Emergency General Surgery, Manchester Royal Infirmary, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanaji","family":"Dasgupta","sequence":"additional","affiliation":[{"name":"Swindon Renal Unit, Great Western Hospital Foundation NHS Trust, Swindon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,3,23]]},"reference":[{"key":"2025082801413372000_15.3.e245156.1","doi-asserted-by":"crossref","DOI":"10.1097\/00007890-201407151-02187","article-title":"Transplantation after encapsulating peritoneal sclerosis: gold standard treatment","volume":"98","author":"Moinuddin","year":"2014","journal-title":"Transplantation"},{"key":"2025082801413372000_15.3.e245156.2","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2017.00018"},{"key":"2025082801413372000_15.3.e245156.3","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMra1505292","article-title":"Calciphylaxis","volume":"378","author":"Nigwekar","year":"2018","journal-title":"N Engl J Med"},{"key":"2025082801413372000_15.3.e245156.4","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2011.107"},{"key":"2025082801413372000_15.3.e245156.5","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.06.020"},{"key":"2025082801413372000_15.3.e245156.6","first-page":"8","article-title":"Encapsulating Peritoneal Sclerosis - A rare and serious complication of peritoneal dialysis: Case series","volume":"7 Spec No. 3","author":"Mihalache","year":"2014","journal-title":"J Med Life"},{"key":"2025082801413372000_15.3.e245156.7","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-020-01722-y","article-title":"Calciphylaxis epidemiology, risk factors, treatment and survival among French chronic kidney disease patients: a case-control study","volume":"21","author":"Gaisne","year":"2020","journal-title":"BMC Nephrol"},{"key":"2025082801413372000_15.3.e245156.8","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s11606-014-2910-1","article-title":"Quantifying a rare disease in administrative data: the example of Calciphylaxis","volume":"29","author":"Nigwekar","year":"2014","journal-title":"J Gen Intern Med"},{"key":"2025082801413372000_15.3.e245156.9","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv438"},{"key":"2025082801413372000_15.3.e245156.10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-020-02067-2","article-title":"Pain management in patients with end-stage renal disease and calciphylaxis- a survey of clinical practices among physicians","volume":"21","author":"Chinnadurai","year":"2020","journal-title":"BMC Nephrol"},{"key":"2025082801413372000_15.3.e245156.11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/MNH.0000000000000328","article-title":"Calciphylaxis","volume":"26","author":"Nigwekar","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2025082801413372000_15.3.e245156.12","unstructured":"Westphal SG , Plumb T . Calciphylaxis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2020."},{"key":"2025082801413372000_15.3.e245156.13","doi-asserted-by":"publisher","DOI":"10.1136\/pmj.77.911.557"},{"key":"2025082801413372000_15.3.e245156.14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/089686080902900508","article-title":"Computed tomographic findings characteristic for encapsulating peritoneal sclerosis: a case-control study","volume":"29","author":"Vlijm","year":"2009","journal-title":"Perit Dial Int"},{"key":"2025082801413372000_15.3.e245156.15","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.2215\/CJN.01820408","article-title":"Assessing the validity of an abdominal CT scoring system in the diagnosis of encapsulating peritoneal sclerosis","volume":"3","author":"Tarzi","year":"2008","journal-title":"CJASN"},{"key":"2025082801413372000_15.3.e245156.16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4158\/EP10349.RA","article-title":"Calciphylaxis due to hyperparathyroidism","volume":"17 Suppl 1","author":"Roy","year":"2011","journal-title":"Endocr Pract"},{"key":"2025082801413372000_15.3.e245156.17","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jamadermatol.2016.4821","article-title":"Warfarin-Associated nonuremic Calciphylaxis","volume":"153","author":"Yu","year":"2017","journal-title":"JAMA Dermatol"},{"key":"2025082801413372000_15.3.e245156.18","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl372"},{"key":"2025082801413372000_15.3.e245156.19","unstructured":"NHS England . Encapsulating peritoneal sclerosis treatment service adults, A07\/S(HSS)a, 2018. Available: https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2018\/08\/Encapsulating-peritoneal-sclerosis-treatment-service-adults.pdf [Accessed 5 Jun 2021]."},{"key":"2025082801413372000_15.3.e245156.20","unstructured":"Burton J , Goldsmith D , Ruddock MN . Commentary on the KDIGO guideline on the diagnosis, evaluation, prevention and treatment of CKD-MBD."},{"key":"2025082801413372000_15.3.e245156.21","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz204"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2021-245156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:41:44Z","timestamp":1756370504000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2021-245156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,23]]},"published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1136\/bcr-2021-245156"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2021-245156","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}